Table 1.
Experimental design
| Treatment | Trial | Days of age |
Days PI |
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 7 | 10 | 10 h | 3 | 6 | 9 | 12 | 14 | ||
| CsAa | 1 | x | x | x | x | ||||||||
| 2 | x | x | x | x | x | x | x | ||||||
| CYb | 1,2 | x | x | x | |||||||||
| SRBCc | 1,2 | x | |||||||||||
| Con Ad | 1,2 | x | |||||||||||
| TCVe | 1,2 | x | |||||||||||
| BWf | 1,2 | x | x | ||||||||||
| IFAg | 1 | x | x | x | |||||||||
| 2 | x | x | |||||||||||
Turkey poults were treated with CsA, 100mg per kg body weight, at every third day as indicated.
Turkey poults were treated with CY, 5mg per turkey poult per day on the first 3 days post-hatching.
Turkey poults were intramuscularly injected with SRBC at 10 days of age. Antibody titers to SRBC were determined by hemagglutination at 7 days after injection.
Lymphocyte proliferation responses to Con A.
Turkey poults were infected with TCV at 10 days of age.
Body weight (BW) gain was determined from 10 (prior to infection) to 19 days of age.
IFA for TCV antigen in the intestine.